Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

2.

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Tesson B, Huet S, Grange B, Jallades L, Baseggio L, Felman P, Traverse-Glehen A, Magaud JP, Lega JC, Bole-Feysot C, Salles G, Callet-Bauchu E, Sujobert P.

Blood. 2017 Sep 7;130(10):1267-1269. doi: 10.1182/blood-2017-03-776674. Epub 2017 Jul 5. No abstract available.

3.

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

Traverse-Glehen A, Verney A, Gazzo S, Jallades L, Chabane K, Hayette S, Coiffier B, Callet-Bauchu E, Ffrench M, Felman P, Berger F, Baseggio L, Salles G.

Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27.

PMID:
27347751
4.

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.

Brisou G, Verney A, Wenner T, Baseggio L, Felman P, Callet-Bauchu E, Coiffier B, Berger F, Salles G, Traverse-Glehen A.

Haematologica. 2014 Oct;99(10):e197-8. doi: 10.3324/haematol.2014.107680. Epub 2014 Jul 4. No abstract available.

5.

Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells.

Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, Magaud JP, Baseggio L.

J Clin Lab Anal. 2015 Mar;29(2):153-61. doi: 10.1002/jcla.21744. Epub 2014 Mar 20.

PMID:
24652675
6.

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

Sarkozy C, Baseggio L, Feugier P, Callet-Bauchu E, Karlin L, Seymour JF, Lebras L, Michallet AS, Offner F, Dumas O, Traverse-Glehen A, Ffrench M, Lopez-Guillermo A, Berger F, Coiffier B, Felman P, Salles G.

Br J Haematol. 2014 Mar;164(5):659-67. doi: 10.1111/bjh.12675. Epub 2013 Nov 26.

PMID:
24274024
7.

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

Lenglet J, Traullé C, Mounier N, Benet C, Munoz-Bongrand N, Amorin S, Noguera ME, Traverse-Glehen A, Ffrench M, Baseggio L, Felman P, Callet-Bauchu E, Brice P, Berger F, Salles G, Brière J, Coiffier B, Thieblemont C.

Leuk Lymphoma. 2014 Aug;55(8):1854-60. doi: 10.3109/10428194.2013.861067. Epub 2014 May 6.

PMID:
24206091
8.

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.

Traverse-Glehen A, Bachy E, Baseggio L, Callet-Bauchu E, Gazzo S, Verney A, Hayette S, Jallades L, Ffrench M, Salles G, Coiffier B, Felman P, Berger F.

Histopathology. 2013 May;62(6):876-93. doi: 10.1111/his.12092.

PMID:
23611359
9.

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.

Miguet L, Lennon S, Baseggio L, Traverse-Glehen A, Berger F, Perrusson N, Chenard MP, Galoisy AC, Eischen A, Mayeur-Rousse C, Maar A, Fornecker L, Herbrecht R, Felman P, Van Dorsselaer A, Carapito C, Cianférani S, Mauvieux L.

Leukemia. 2013 Aug;27(8):1748-50. doi: 10.1038/leu.2013.3. Epub 2013 Jan 10. No abstract available.

PMID:
23302770
10.

Pertinence of the Sysmex XE-5000™ parameters: rule of slide review in a context of 'normal' lymphocyte count (defined from control and mantle cell lymphoma blood specimens).

Chhuy J, Morel D, Goeddert G, Magaud JP, Felman P, Baseggio L.

Int J Lab Hematol. 2013 Oct;35(5):510-6. doi: 10.1111/ijlh.12042. Epub 2012 Dec 27.

PMID:
23279807
11.

Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.

Bikos V, Stalika E, Baliakas P, Darzentas N, Davis Z, Traverse-Glehen A, Dagklis A, Kanellis G, Anagnostopoulos A, Tsaftaris A, Ponzoni M, Berger F, Felman P, Ghia P, Papadaki T, Oscier D, Belessi C, Stamatopoulos K.

Leukemia. 2012 Dec;26(12):2567-9. doi: 10.1038/leu.2012.207. Epub 2012 Jun 18. No abstract available.

PMID:
22858907
12.

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

Baseggio L, Geay MO, Gazzo S, Berger F, Traverse-Glehen A, Ffrench M, Hayette S, Callet-Bauchu E, Verney A, Morel D, Jallades L, Magaud JP, Salles G, Felman P.

Br J Haematol. 2012 Aug;158(4):489-98. doi: 10.1111/j.1365-2141.2012.09178.x. Epub 2012 Jun 12.

PMID:
22686190
13.

Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.

Traverse-Glehen A, Baseggio L, Salles G, Coiffier B, Felman P, Berger F.

Discov Med. 2012 Apr;13(71):253-65. Review.

14.

Splenic marginal zone lymphoma: current knowledge and future directions.

Thieblemont C, Davi F, Noguera ME, Brière J, Bertoni F, Zucca E, Traverse-Glehen A, Felman P, Berger F, Salles G, Coiffier B.

Oncology (Williston Park). 2012 Feb;26(2):194-202.

15.

Unusual spheroids in cerebrospinal fluid.

Jallades L, Jourdy Y, Morel D, Goedert G, Baseggio L, Felman P.

Eur J Haematol. 2012 Jul;89(1):94. doi: 10.1111/j.1600-0609.2012.01758.x. Epub 2012 Feb 14. No abstract available.

PMID:
22268565
16.

Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm.

Gilis L, Lebras L, Bouafia-Sauvy F, Espinouse D, Felman P, Berger F, Salles G, Coiffier B, Michallet AS.

Leuk Lymphoma. 2012 Aug;53(8):1633-7. doi: 10.3109/10428194.2012.656627. Epub 2012 Mar 16. No abstract available.

PMID:
22260159
17.

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.

Bikos V, Darzentas N, Hadzidimitriou A, Davis Z, Hockley S, Traverse-Glehen A, Algara P, Santoro A, Gonzalez D, Mollejo M, Dagklis A, Gangemi F, Bosler DS, Bourikas G, Anagnostopoulos A, Tsaftaris A, Iannitto E, Ponzoni M, Felman P, Berger F, Belessi C, Ghia P, Papadaki T, Dogan A, Degano M, Matutes E, Piris MA, Oscier D, Stamatopoulos K.

Leukemia. 2012 Jul;26(7):1638-46. doi: 10.1038/leu.2012.3. Epub 2012 Jan 6.

PMID:
22222599
18.

Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.

Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F.

Curr Opin Oncol. 2011 Sep;23(5):441-8. doi: 10.1097/CCO.0b013e328349ab8d. Review.

PMID:
21760505
19.

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma.

Baseggio L, Traverse-Glehen A, Berger F, Ffrench M, Jallades L, Morel D, Goedert G, Magaud JP, Salles G, Felman P.

Mod Pathol. 2011 Jul;24(7):993-1003. doi: 10.1038/modpathol.2011.53. Epub 2011 Apr 15.

20.

Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.

Rolland D, Bouamrani A, Houlgatte R, Barbarat A, Ramus C, Arlotto M, Ballester B, Berger F, Felman P, Callet-Bauchu E, Baseggio L, Traverse-Glehen A, Brugière S, Garin J, Coiffier B, Berger F, Thieblemont C.

Leuk Lymphoma. 2011 Apr;52(4):648-58. doi: 10.3109/10428194.2010.549256. Epub 2011 Jan 11.

PMID:
21438832
21.

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).

Baseggio L, Traverse-Glehen A, Callet-Bauchu E, Morel D, Magaud JP, Berger F, Salles G, Felman P.

Hematol Oncol. 2011 Mar;29(1):47-51. doi: 10.1002/hon.957.

PMID:
20677173
22.

Simultaneous detection of clonal expansion of large granular lymphocytes and breast cancer in blood.

Baseggio L, Regad AL, Ffrench M, Felman P.

Leuk Res. 2010 Nov;34(11):e304-5. doi: 10.1016/j.leukres.2010.06.008. Epub 2010 Jul 3. No abstract available.

PMID:
20598744
23.

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

Salido M, Baró C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, Traverse-Glehen A, Berger F, Felman P, Thieblemont C, Gesk S, Athanasiadou A, Davis Z, Gardiner A, Milla F, Ferrer A, Mollejo M, Calasanz MJ, Florensa L, Espinet B, Luño E, Wlodarska I, Verhoef G, García-Granero M, Salar A, Papadaki T, Serrano S, Piris MA, Solé F.

Blood. 2010 Sep 2;116(9):1479-88. doi: 10.1182/blood-2010-02-267476. Epub 2010 May 17.

24.

Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?

Traverse-Glehen A, Baseggio L, Callet-Bauchu E, Ffrench M, Coiffier B, Salles G, Felman P, Berger F.

Br J Haematol. 2010 Jul;150(1):113-6. doi: 10.1111/j.1365-2141.2010.08153.x. Epub 2010 Mar 11. No abstract available.

PMID:
20230408
25.

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, Couris CM, Thieblemont C, Morel D, Coiffier B, Salles G, Felman P.

Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.

26.

Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.

Johnston A, Salles G, Espinouse D, Felman P, André P, Berger F, Coiffier B.

Clin Lymphoma Myeloma. 2008 Dec;8(6):356-8. doi: 10.3816/CLM.2008.n.052.

PMID:
19064401
27.

Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.

Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Houlgatte R, Fu K, Weisenburger D, De Jong D, Jaffe ES, Rosenwald A, Ott G, Coiffier B, Berger F.

Leuk Lymphoma. 2008 Jul;49(7):1403-6. doi: 10.1080/10428190802094245. No abstract available.

28.

The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.

Chapiro E, Radford-Weiss I, Bastard C, Luquet I, Lefebvre C, Callet-Bauchu E, Leroux D, Talmant P, Mozziconacci MJ, Mugneret F, Struski S, Raynaud S, Andrieux J, Barin C, Jotterand M, Mossafa H, Ramond S, Terré C, Lippert E, Berger F, Felman P, Merle-Béral H, Bernard OA, Davi F, Berger R, Nguyen-Khac F.

Leukemia. 2008 Nov;22(11):2123-7. doi: 10.1038/leu.2008.102. Epub 2008 May 1. No abstract available.

PMID:
18449207
29.

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Solé F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA.

Leukemia. 2008 Mar;22(3):487-95. Epub 2007 Dec 20. Review.

PMID:
18094718
30.

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, Verney A, Rolland D, Thieblemont C, Magaud JP, Salles G, Coiffier B, Berger F, Felman P.

Blood. 2008 Feb 15;111(4):2253-60. Epub 2007 Nov 27.

31.

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.

Gazzo S, Chudoba I, Traverse-Glehen A, Baseggio L, Felman P, Berger F, Salles G, Hayette S, Magaud JP, Callet-Bauchu E.

Cancer Genet Cytogenet. 2007 Jun;175(2):159-65.

PMID:
17556073
32.

A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.

Martín-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, De Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Küppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Solé F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R.

Leukemia. 2007 Jul;21(7):1532-44. Epub 2007 May 10.

PMID:
17495977
33.

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.

Traverse-Glehen A, Verney A, Baseggio L, Felman P, Callet-Bauchu E, Thieblemont C, Ffrench M, Magaud JP, Coiffier B, Berger F, Salles G.

Leukemia. 2007 Aug;21(8):1821-4. Epub 2007 May 3. No abstract available.

PMID:
17476282
34.

The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell.

Baseggio L, Berger F, Monneret G, Magaud JP, Salles G, Felman P.

Haematologica. 2006 Dec;91(12):1717-9.

35.

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

Ghesquières H, Berger F, Felman P, Callet-Bauchu E, Bryon PA, Traverse-Glehen A, Thieblemont C, Baseggio L, Michallet AS, Coiffier B, Salles G.

J Clin Oncol. 2006 Nov 20;24(33):5234-41. Epub 2006 Oct 16.

PMID:
17043351
36.

Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas.

de la Fouchardiere A, Gazzo S, Balme B, Chouvet B, Felman P, Coiffier B, Salles G, Callet-Bauchu E, Berger F.

Am J Dermatopathol. 2006 Aug;28(4):287-92.

PMID:
16871031
37.

A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.

Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA, Thieblemont C, Coiffier B, Salles G, Berger F.

Histopathology. 2006 Jan;48(2):162-73.

PMID:
16405665
38.

Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma.

Baseggio L, Berger F, Morel D, Delfau-Larue MH, Goedert G, Salles G, Magaud JP, Felman P.

Leukemia. 2006 Feb;20(2):296-303.

PMID:
16341050
39.

Atypical cytogenetic presentation of t(11;14) in mantle cell lymphoma.

Gazzo S, Felman P, Berger F, Salles G, Magaud JP, Callet-Bauchu E.

Haematologica. 2005 Dec;90(12):1708-9.

40.

An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement.

Baseggio L, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Thieblemont C, Bryon PA, Magaud JP, Berger F, Felman P.

Leuk Lymphoma. 2005 Sep;46(9):1369-74.

PMID:
16109617
41.

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.

Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, Morel D, Gazzo S, Poncet C, Thieblemont C, Coiffier B, Magaud JP, Salles G.

Leukemia. 2005 Oct;19(10):1818-23.

PMID:
16094418
42.

[Pathological and clinical correlations in primary cutaneous B-cell lymphomas: a series of 44 cases].

de la Fouchardière A, Balme B, Chouvet B, Perrot H, Thomas L, Claudy A, Felman P, Salles G, Coiffier B, Berger F.

Ann Pathol. 2005 Feb;25(1):8-17. Review. French.

PMID:
15981927
43.

Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L, Gazzo S, Thieblemont C, Charlot C, Coiffier B, Berger F, Salles G.

Haematologica. 2005 Apr;90(4):470-8.

44.

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B.

Clin Lymphoma. 2005 Mar;5(4):220-4. Review.

PMID:
15794852
45.

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.

Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, Loriod B, Granjeaud S, Gaulard P, Haioun C, Traverse-Glehen A, Baseggio L, Bertucci F, Birnbaum D, Magrangeas F, Minvielle S, Avet-Loiseau H, Salles G, Coiffier B, Berger F, Houlgatte R.

Blood. 2004 Apr 1;103(7):2727-37. Epub 2003 Nov 20.

46.

High-grade canine T-cell lymphoma/leukemia with plasmacytoid morphology: a clinical pathological study of nine cases.

Ponce F, Magnol JP, Marchal T, Chabanne L, Ledieu D, Bonnefont C, Felman P, Fournel-Fleury C.

J Vet Diagn Invest. 2003 Jul;15(4):330-7.

PMID:
12918813
47.

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene.

Hayette S, Tigaud I, Callet-Bauchu E, Ffrench M, Gazzo S, Wahbi K, Callanan M, Felman P, Dumontet C, Magaud JP, Rimokh R.

Blood. 2003 Aug 15;102(4):1549-50. No abstract available.

48.

Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001.

Thieblemont C, Dumontet C, Bouafia F, Hequet O, Arnaud P, Espinouse D, Felman P, Berger F, Salles G, Coiffier B.

Leuk Lymphoma. 2003 Feb;44(2):257-62.

PMID:
12688342
49.

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.

Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, Coiffier B.

Lancet Oncol. 2003 Feb;4(2):95-103. Review.

PMID:
12573351
50.

Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma.

Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, Coiffier B, Felman P, Berger F, Salles G, Callet-Bauchu E.

Haematologica. 2003 Jan;88(1):31-8.

Supplemental Content

Loading ...
Support Center